Breaking News

Stevanato Group, CEPI Ink Agreement for 100M Glass Vials for COVID-19 Vaccines

To supply of 100 million Type 1 Borosilicate glass vials to hold up to 2 billion doses of a COVID-19 vaccine, should product(s) be proven safe and effective.

By: Contract Pharma

Contract Pharma Staff

Stevanato Group, a producer of pharmaceutical glass containers and drug delivery systems, and CEPI (the Coalition for Epidemic Preparedness Innovations), signed an agreement for the supply of 100 million Type 1 Borosilicate glass vials to hold up to 2 billion doses of a COVID-19 vaccine, should product(s) be proven safe and effective. This supply is part of CEPI’s efforts to rapidly speed up the vaccine development timeline through making progress on manufacturing in parallel with the clinical d...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters